Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-27

Clinical Trial Update: The Effect Tenofovir Disoproxil Fumarate (TDF) and Tenofovir Alafenamide (TAF) on Small Intestine Gut Wall [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) on the small intestine gut wall in HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAF (tenofovir alafenamide)
  • TDF (tenofovir disoproxil fumarate)

Snippet

Sponsor: Jussi Sutinen | Conditions: HIV Infections, Weight Gain | Phase 4 | Status: UNKNOWN